1. Home
  2. NRXP vs SWIN Comparison

NRXP vs SWIN Comparison

Compare NRXP & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • SWIN
  • Stock Information
  • Founded
  • NRXP 2015
  • SWIN 2017
  • Country
  • NRXP United States
  • SWIN Hong Kong
  • Employees
  • NRXP N/A
  • SWIN N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • SWIN
  • Sector
  • NRXP Health Care
  • SWIN
  • Exchange
  • NRXP Nasdaq
  • SWIN Nasdaq
  • Market Cap
  • NRXP 32.6M
  • SWIN 32.1M
  • IPO Year
  • NRXP N/A
  • SWIN 2023
  • Fundamental
  • Price
  • NRXP $3.50
  • SWIN $3.06
  • Analyst Decision
  • NRXP Strong Buy
  • SWIN
  • Analyst Count
  • NRXP 4
  • SWIN 0
  • Target Price
  • NRXP $28.50
  • SWIN N/A
  • AVG Volume (30 Days)
  • NRXP 295.0K
  • SWIN 292.8K
  • Earning Date
  • NRXP 08-13-2025
  • SWIN 08-21-2025
  • Dividend Yield
  • NRXP N/A
  • SWIN N/A
  • EPS Growth
  • NRXP N/A
  • SWIN N/A
  • EPS
  • NRXP N/A
  • SWIN N/A
  • Revenue
  • NRXP N/A
  • SWIN $2,419,000.00
  • Revenue This Year
  • NRXP N/A
  • SWIN N/A
  • Revenue Next Year
  • NRXP N/A
  • SWIN $61.68
  • P/E Ratio
  • NRXP N/A
  • SWIN N/A
  • Revenue Growth
  • NRXP N/A
  • SWIN N/A
  • 52 Week Low
  • NRXP $1.10
  • SWIN $1.16
  • 52 Week High
  • NRXP $6.01
  • SWIN $4.17
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 66.15
  • SWIN 79.41
  • Support Level
  • NRXP $2.90
  • SWIN $1.57
  • Resistance Level
  • NRXP $3.61
  • SWIN $3.48
  • Average True Range (ATR)
  • NRXP 0.28
  • SWIN 0.26
  • MACD
  • NRXP -0.03
  • SWIN 0.13
  • Stochastic Oscillator
  • NRXP 64.59
  • SWIN 78.05

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About SWIN Solowin Holdings

Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.

Share on Social Networks: